International Journal of Clinical Research

Objective: To observe the efficacy of ornidazole and metronidazole in the treatment of trichomonal vaginitis. Methods From May 2021 to October 2022, 68 patients with trichomonal vaginitis were selected as subjects, and randomly divided into a control group treated with metronidazole and an observation group treated with ornidazole using a digital table. The recovery status of the two groups of patients was statistically analyzed. Results During the treatment period, the improvement time of symptoms in the observation group was shorter than that in the control group (P<0.05). The level of inflammatory factors in patients before and after treatment in the observation group was lower than that in the control group after treatment, P<0.05. During the medication period, the adverse reactions in the observation group were lower than those in the control group (P<0.05). There was no difference in clinical symptom scores, vaginal pH, and vaginal cleanliness between the two groups before treatment (P>0.05). After treatment, there was a significant advantage in the observation group (P<0.05). Conclusion In the treatment of trichomonal vaginitis, ornidazole is more effective and safe.

Trichomonal vaginitis; Ornidazole; metronidazole